28Jan 2021
Final analysis of the randomized trial on imatinib as an adjuvant in localized gastrointestinal stromal tumors

Final analysis of the randomized trial on imatinib as an adjuvant in localized gastrointestinal stromal tumors

In 2004, we started an intergroup randomized trial of adjuvant imatinib versus no further therapy after R0-R1 surgery in localized, high/intermediate-risk GIST patients. Interim analysis results were published in 2015 upon recommendation from an independent data review committee.

  • #oncology

Like

Save

Share